Yukio Chiba

856 citations
40 papers · 676 indexed · h-index 14
Topics
Angiogenesis and VEGF in Cancer (5 papers)Lung Cancer Diagnosis and Treatment (4 papers)Metastasis and carcinoma case studies (4 papers)
Partner nations
JapanChina

In The Last Decade

Yukio Chiba

32 papers receiving 645 citations

Peers

Yukio Chiba
Comparison fields: 5 of 66
  • Molecular Biology 225
  • Surgery 210
  • Pulmonary and Respiratory Medicine 197
  • Oncology 179
  • Epidemiology 104
Replace Hiroshi Kawamata with:
Hiroshi Kawamata Japan
Toshiro Ogata Japan
Sanai Noguchi Japan
K Jaśkiewicz South Africa
Norio Hirabayashi Japan
Yongjie Shui China
Hideo Takamatsu Japan
J. M. Gokel Germany
Yidong Cai China
Y Kuroda Japan
Yukio Chiba relative to Hiroshi Kawamata Japan Hiroshi Kawamata's profile →
Citations per field
00.5×1.7×
Hiroshi Kawamata · 1×
Citations per year

Countries citing papers authored by Yukio Chiba

Since Specialization
Citations

This map shows the geographic impact of Yukio Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Chiba more than expected).

Fields of papers citing papers by Yukio Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukio Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Chiba. The network helps show where Yukio Chiba may publish in the future.

Co-authorship network of co-authors of Yukio Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Yukio Chiba. A scholar is included among the top collaborators of Yukio Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukio Chiba. Yukio Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 40
2 37
3 27
4 30
5 56
6 0
7 3
8 7
9 6
10 10
11 1
12 66
13 6
14 0
15 2
16 1
17 44
18 2
19 0
20 5

About Yukio Chiba

Yukio Chiba is a scholar working on Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 676 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Metastasis and carcinoma case studies (4 papers). The work is most often cited by research in Hepatology (99 citations), Oncology (179 citations) and Cancer Research (94 citations). Yukio Chiba has collaborated with scholars based in Japan and China. Frequent co-authors include R Muraoka, Akio Ihaya, Nobuhiko Tanigawa, Kuniyoshi Tanaka, Yasushi Kato, Masato Sasaki, Takahiko Uesaka, Tetsuya Horiuchi, Tomoaki Nakamura and Masanori Nakanishi. Their work appears in journals such as American Journal of Physiology-Heart and Circulatory Physiology, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026